BridgeBio Pharma Inc.
(BBIO)
undefined
undefined%
At close: undefined
27.49
-0.04%
After-hours Dec 13, 2024, 04:15 PM EST
Ratios (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| PE Ratio | -2.55 | -0.57 | -0.94 | -4.33 | -3.54 | -4.86 | -20.81 |
| PS Ratio | 176.61 | 3.62 | 8.63 | 254.29 | 22.71 | 0.00 | 0.00 |
| PB Ratio | -1.21 | -0.22 | -0.69 | 36.23 | 2.25 | -3.88 | -10.96 |
| P/FCF Ratio | -3.11 | -0.66 | -1.10 | -5.15 | -3.56 | -4.11 | -15.53 |
| P/OCF Ratio | -3.11 | -0.67 | -1.21 | -5.25 | -3.63 | -4.65 | -15.71 |
| OCF/S Ratio | -14.18 | -1.35 | -1.79 | -12.11 | -1.56 | 0.00 | 0.00 |
| Debt / Equity Ratio | -0.32 | -0.34 | -0.49 | 2.06 | 0.06 | -0.08 | -0.62 |
| Quick Ratio | 0.83 | 0.99 | 1.75 | 1.75 | 2.86 | 3.42 | 2.84 |
| Current Ratio | 0.83 | 1.07 | 1.61 | 1.75 | 2.86 | 3.42 | 2.84 |
| Asset Turnover | 0.02 | 0.12 | 0.07 | 0.01 | 0.06 | 0.00 | 0.00 |
| Interest Coverage | -1.87 | -1.47 | -3.10 | -3.24 | -7.59 | -18.03 | -843.42 |
| Return on Equity (ROE) | 47.49% | 39.37% | 73.45% | -835.71% | -63.76% | 79.73% | 52.68% |
| Return on Assets (ROA) | -117.72% | -79.28% | -63.12% | -68.78% | -41.23% | -28.12% | -31.17% |
| Return on Capital (ROIC) | -150.89% | -93.39% | -65.68% | -77.56% | -45.96% | -42.48% | -49.01% |
| Dividend Yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.03% | 0.00% | 0.05% |
| Payout Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -0.10% | 0.00% | -0.94% |
| Gross Profit Margin | 18.43% | 23.89% | 23.88% | 15.64% | 23.46% | 0.00% | 0.00% |
| Net Profit Margin | -1728.48% | -159.04% | -229.25% | -1466.62% | -160.53% | 0.00% | 0.00% |